Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Foxp1 controls Fezf2-dependent gene expression, mimetic mTEC diversity, and thymic central tolerance.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 17, 2026
Runx3 instructs Aire+ mTEC development, TSA gene expression, and central tolerance.
Journal: Journal of autoimmunity
Published: February 05, 2026
ATF7ip Inhibits the Tumor Immune Response by Promoting Terminal CD8+ T-cell Exhaustion.
Journal: Cancer immunology research
Published: July 07, 2025
Thymic alveolar type 2 epithelial mimetic cells revealed by RUNX1 deficiency.
Journal: Nature immunology
Published: February 11, 2025
A balancing act in the control of self-antigen expression.
Journal: Nature immunology
Published: August 21, 2024
ATF7ip Targets Transposable Elements for H3K9me3 Deposition to Modify CD8+ T Cell Effector and Memory Responses.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 18, 2021
Gene Expression Meta-Analysis Reveals Concordance in Gene Activation, Pathway, and Cell-Type Enrichment in Dermatomyositis Target Tissues.
Journal: ACR open rheumatology
Published: June 19, 2019
The epigenetic regulator ATF7ip inhibits Il2 expression, regulating Th17 responses.
Journal: The Journal of experimental medicine
Published: December 14, 2018
Last Updated: 09/26/2026